Reversible posterior leukoencephalopathy syndrome complicating cytotoxic chemotherapy for hematologic malignancies

American Journal of Hematology

Volumn 77, Issue 1, 2004, Pages 72-76

  Tam, C S ^a   Galanos, J ^a   Seymour, J F ^a   Pitman, A G ^a   Stark, R J ^a,b,c   Prince, H M ^a  

^a PETER MACCALLUM CANCER CENTRE   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c MONASH UNIVERSITY   (Australia)

Author keywords

Cyclosporine encephalopathy; Cytotoxic chemotherapy; Eclampsia; Hypertensive encephalopathy; Posterior leukoencephalopathy

Indexed keywords

ANTINEOPLASTIC AGENT; ATENOLOL; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; CYTOTOXIC AGENT; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; GLYCERYL TRINITRATE; HYDRALAZINE; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; THALIDOMIDE;

ADULT; ANTIHYPERTENSIVE THERAPY; ARTICLE; BRAIN EDEMA; CANCER CHEMOTHERAPY; CASE REPORT; CEREBELLUM DISEASE; COGNITIVE DEFECT; DISEASE ASSOCIATION; ECLAMPSIA; FLUID RETENTION; HEADACHE; HEMATOLOGIC MALIGNANCY; HUMAN; HYPERTENSION; HYPERTENSION ENCEPHALOPATHY; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FAILURE; LEUKOENCEPHALOPATHY; LYMPHOBLASTOMA; MALE; MULTIPLE MYELOMA; PRIORITY JOURNAL; REVERSIBLE POSTERIOR LEUKOENCEPHALOPATHY SYNDROME; SEIZURE; VISUAL DISORDER; WHITE MATTER;

AGED; ANTINEOPLASTIC AGENTS; EDEMA; FATAL OUTCOME; HEMATOLOGIC NEOPLASMS; HUMANS; HYPERTENSION; HYPERTENSIVE ENCEPHALOPATHY; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED;

EID: 4243057261     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/ajh.20147     Document Type: Article

References (28)

1. Ay H, Buonanno FS, Schaefer PW, et al. Posterior leukoencephalopathy without severe hypertension: utility of diffusion-weighted MRI. Neurology 1998;51:1369-1376.
2. Bakshi R, Shaikh ZA, Bates VE, Kinkel PR. Thrombotic thrombocytopenic purpura: brain CT and MRI findings in 12 patients. Neurology 1999;52:1285.
3. Beausang-Linder M, Bill A. Cerebral circulation in acute arterial hypertension-protective effects of sympathetic nervous activity. Acta Physiol Scand 1981;111:193-199.
4. Cain MS, Burton GV, Holcombe RF. Fatal leukoencephalopathy in a patient with non-Hodgkin's lymphoma treated with CHOP chemotherapy and high-dose steroids. Am J Med Sci 1998;315: 202-207.
5. Delanty N, Vaughan C, Frucht S, Stubgen P. Erythropoietin-associated hypertensive posterior leukoencephalopathy. Neurology 1997;49:686-689.
6. Edvinsson L, Owman C, Sjoberg NO. Autonomic nerves, mast cells, and amine receptors in human brain vessels. A histochemical and pharmacological study. Brain Res 1976;115:377-393.
7. Edwards MJ, Walker R, Vinnicombe S, Barlow C, MacCallum P, Foran JM. Reversible posterior leukoencephalopathy syndrome following CHOP chemotherapy for diffuse large B-cell lymphoma. Ann Oncol 2001;12:1327-1329.
8. Faraci M, Lanino E, Dini G, et al. Severe neurologic complications after hematopoietic stem cell transplantation in children. Neurology 2002;59:1895-1904.
9. Greenwood MJ, Dodds AJ, Garricik R, Rodriguez M. Posterior leukoencephalopathy in association with the tumour lysis syndrome in acute lymphoblastic leukaemia-a case with clinicopathological correlation. Leuk Lymphoma 2003;44:719-721.
10. Henderson JN, Noetzel MJ, McKinstry RC, White DA, Armstrong M, DeBaun MR. Reversible posterior leukoencephalopathy syndrome and silent cerebral infarcts are associated with severe acute chest syndrome in children with sickle cell disease. Blood 2003;101:415-419.
11. Henderson RD, Rajah T, Nicol AJ, Read SJ. Posterior leukoencephalopathy following intrathecal chemotherapy with MRA-documented vasospasm. Neurology 2003;60:326-328.
12. Higman MA, Port JD, Beauchamp NJ Jr, Chen AR. Reversible leukoencephalopathy associated with re-infusion of DMSO preserved stem cells. Bone Marrow Transplant 2000;26:797-800.
13. Hinchey J, Chaves C, Appignani B, et al. A reversible posterior leukoencephalopathy syndrome. N Engl J Med 1996;334:494-500.
14. Honkaniemi J, Kahara V, Dastidar P, et al. Reversible posterior leukoencephalopathy after combination chemotherapy. Neuroradiology 2000;42:895-899.
15. Ito Y, Arahata Y, Goto Y, et al. Cisplatin neurotoxicity presenting as reversible posterior leukoencephalopathy syndrome. AJNR Am J Neuroradiol 1998;19:415-417.
16. Ito Y, Niwa H, Iida T, et al. Post-transfusion reversible posterior leukoencephalopathy syndrome with cerebral vasoconstriction. Neurology 1997;49:1174-1175.
17. Kastrup O, Diener HC. Granulocyte-stimulating factor filgrastim and molgramostim induced recurring encephalopathy and focal status epilepticus, J Neurol 1997;244:274-275.
18. Kastrup O, Maschke M, Wanke I, Diener HC. Posterior reversible encephalopathy syndrome due to severe hypercalcemia. J Neurol 2002;249:1563-1566.
19. Kupferschmidt H, Bont A, Schnorf H, et al. Transient cortical blindness and bioccipital brain lesions in two patients with acute intermittent porphyria. Ann Intern Med 1995;123:598-600.
20. Lee C-K, Barlogie B, Munshi N, et al. DTPACE: an effective, novel combination chemotherapy with thalidomide for previously treated patients with myeloma. J Clin Oncol 2003;21: 2732-2739.
21. Mukherjee P, McKinstry RC. Reversible posterior leukoencephalopathy syndrome: evaluation with diffusion-tensor MR imaging. Radiology 2001;219:756-765.
22. Pavlakis SG, Frank Y, Chusid R. Hypertensive encephalopathy, reversible occipitoparietal encephalopathy, or reversible posterior leukoencephalopathy: three names for an old syndrome. J Child Neurol 1999;14:277-281.
23. Schwartz RB, Bravo SM, Klufas RA, et al. Cyclosporine neurotoxicity and its relationship to hypertensive encephalopathy: CT and MR findings in 16 cases. AJR Am J Roentgenol 1995;165: 627-631.
24. Shin RK, Stern JW, Janss AJ, Hunter JV, Liu GT. Reversible posterior leukoencephalopathy during the treatment of acute lymphoblastic leukemia. Neurology 2001;56:388-391.
25. Suminoe A, Matsuzaki A, Kira R, et al. Reversible posterior leukoencephalopathy syndrome in children with cancers. J Pediatr Hematol Oncol 2003;25:236-239.
26. Utz N, Kinkel B, Hedde JP, Bewermeyer H. MR imaging of acute intermittent porphyria mimicking reversible posterior leukoencephalopathy syndrome. Neuroradiology 2001;43: 1059-1062.
27. Vaughn DJ, Jarvik JG, Hackney D, Peters S, Stadtmauer EA. High-dose cytarabine neurotoxicity: MR findings during the acute phase. AJNR Am J Neuroradiol 1993;14:1014-1016.
28. Voltz R, Rosen FV, Yousry T, Beck J, Hohlfeld R. Reversible encephalopathy with cerebral vasospasm in a Guillain-Barre syndrome patient treated with intravenous immunoglobulin. Neurology 1996;46:250-251.